Can you provide the last earnings date for EDITAS MEDICINE INC?
EDITAS MEDICINE INC (EDIT) last reported earnings on 3/9/2026.
EDITAS MEDICINE INC (EDIT) Earnings History & Surprises
NASDAQ:EDIT • US28106W1036
Current stock price
2.67 USD
+0.06 (+2.3%)
At close:
2.66 USD
-0.01 (-0.37%)
After Hours:
EDIT Earnings overview
Past quarterly earnings results for EDITAS MEDICINE INC (EDIT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.27
- Revenue Estimate
- 4.494M
Last Reported
Most Recent- Release Date
- Mar 9, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.06
- EPS Surprise
- 77.22%
- Revenue Surprise
- 333.52%
Beat Rate
Last 8 Quarters 44%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.06 | -0.26 | 77.22% | 89.09% | 24.741M | 5.707M | 333.52% | -19.16% |
| Q3 2025 | -0.28 | -0.30 | 7.33% | 62.67% | 7.543M | 5.12M | 47.32% | 12,265.57% |
| Q2 2025 | -0.63 | -0.38 | -63.79% | 23.17% | 3.578M | 1.703M | 110.10% | 597.47% |
| Q1 2025 | -0.92 | -0.60 | -53.11% | -21.05% | 4.658M | 720.12K | 546.84% | 310.40% |
| Q4 2024 | -0.55 | -0.36 | -51.16% | -139.13% | 30.604M | 32.875M | -6.91% | -49.03% |
| Q3 2024 | -0.75 | -0.76 | 1.53% | -36.36% | 61K | 2.289M | -97.34% | -98.86% |
| Q2 2024 | -0.82 | -0.72 | -14.27% | -46.43% | 513K | 5.185M | -90.11% | -82.23% |
| Q1 2024 | -0.76 | -0.68 | -12.10% | -7.04% | 1.135M | 8.063M | -85.92% | -88.48% |
| Q4 2023 | -0.23 | -0.55 | 58.41% | 73.86% | 60.048M | 8.102M | 641.15% | 818.17% |
| Q3 2023 | -0.55 | -0.58 | 5.09% | 32.10% | 5.336M | 3.488M | 52.98% | 13,240.00% |
| Q2 2023 | -0.56 | -0.78 | 28.06% | 28.21% | 2.887M | 4.254M | -32.13% | -54.61% |
| Q1 2023 | -0.71 | -0.80 | 11.21% | 4.05% | 9.851M | 3.068M | 221.09% | 45.51% |
| Q4 2022 | -0.88 | -0.82 | -7.53% | -44.26% | 6.54M | 3.323M | 96.81% | -47.55% |
| Q3 2022 | -0.81 | -0.89 | 8.60% | -42.11% | 40K | 4.801M | -99.17% | -99.35% |
| Q2 2022 | -0.78 | -0.84 | 6.94% | 3.70% | 6.36M | 4.376M | 45.34% | 1,573.68% |
| Q1 2022 | -0.74 | -0.81 | 8.76% | 13.95% | 6.77M | 3.93M | 72.26% | 4.15% |
| Q4 2021 | -0.61 | -0.74 | 17.05% | 39.00% | 12.47M | 4.372M | 185.22% | 9.19% |
| Q3 2021 | -0.57 | -0.83 | 31.53% | -575.00% | 6.2M | 4.872M | 27.26% | -90.13% |
| Q2 2021 | -0.81 | -0.84 | 3.98% | -88.37% | 380K | 6.299M | -93.97% | -96.47% |
| Q1 2021 | -0.86 | -0.75 | -14.81% | -24.64% | 6.5M | 5.891M | 10.34% | 13.64% |
| Q4 2020 | -1.00 | -0.75 | -33.14% | - | 11.42M | 5.756M | 98.40% | - |
| Q3 2020 | 0.12 | -0.65 | 118.50% | - | 62.84M | 6.732M | 833.45% | - |
| Q2 2020 | -0.43 | -0.82 | 47.74% | - | 10.75M | 6.462M | 66.36% | - |
| Q1 2020 | -0.69 | -0.80 | 14.06% | - | 5.72M | 6.86M | -16.62% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-8.09%
Max EPS beat (4)
77.22%
Min EPS beat (4)
-63.79%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
259.45%
Max Revenue beat (4)
546.84%
Min Revenue beat (4)
47.32%
Analysis
In the last 4 quarters, EDIT has beaten EPS estimates in 2 out of 4 releases
EDIT has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, EDIT reported -8.1% below the EPS estimates on average.
In the last 4 quarters, EDIT has beaten the revenue estimates by 259.4% on average.
Related analysis
EDITAS MEDICINE INC / EDIT Earnings FAQ
Did EDIT stock beat earnings estimates in the most recent quarter?
EDITAS MEDICINE INC (EDIT) beat EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often EDITAS MEDICINE INC beats earnings estimates?
In the last 4 quarters, EDITAS MEDICINE INC (EDIT) has beaten EPS estimates in 2 out of 4 releases.